Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

7.05
Delayed Data
As of Aug 28
 -0.03 / -0.42%
Today’s Change
6.18
Today|||52-Week Range
9.68
-2.08%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close7.08
Today’s open7.02
Day’s range6.96 - 7.11
Volume24,093
Average volume (3 months)18,314
Market cap$134.1M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-5.26%
Earnings growth (this year)+91.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+276.37%
P/E ratioNM
Price/Sales8.84
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc+0.23+8.68%
EPIXESSA Pharma Inc+0.26+4.53%
NERVMinerva Neuroscience...+0.02+0.36%
REPHRecro Pharma Inc+1.00+7.64%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateAugust 31, 2015
EPS forecast (this quarter)$0.50
Annual revenue (last year)$15.0M
Annual profit (last year)-$11.1M
Net profit margin-74.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer &
Head-Media Relations
Brian M. Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers